Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Mandiri Herindo Adiperkasa Tbk. (MAHA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Mandiri Herindo Adiperkasa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Mandiri Herindo Adiperkasa Tbk. trades at Rp145 (market cap 2.47T, 1.02M 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 7.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (1.02M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | MAHA | |
|---|---|---|
Market Cap | 316.25B | 2.47T |
Volume | 41.7K | 1.02M |
Lot | 417 | 10.23K |
Turnover | 9.66M | 149.58M |
Average Price | 231.65 | 146.24 |
Value | 9.66M | 149.58M |
Indicative Equilibrium Price | 230 | 145 |
Indicative Equilibrium Volume | 2.4K | 1.03K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Mandiri Herindo Adiperkasa Tbk.
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →
